Danske Invest · DK0010264456 · SFDR Article 8 · compiled 2026-08-24 from holdings the manager publishes about a month in arrears
This fund holds no other funds.
| Company | Weight | Country | Type |
|---|---|---|---|
| Corcept Therapeutics Inc. | 5.580% | United States | Equity |
| NeoGenomics Inc. | 5.100% | United States | Equity |
| Veracyte Inc. | 5.080% | United States | Equity |
| Bruker Corp. | 4.310% | United States | Equity |
| Alkermes Plc | 4.230% | United States | Equity |
| Illumina Inc. | 3.920% | United States | Equity |
| Krystal Biotech Inc. | 3.870% | United States | Equity |
| Natera Inc. | 3.800% | United States | Equity |
| Axsome Therapeutics Inc. | 3.710% | United States | Equity |
| Neurocrine Biosciences Inc. | 3.530% | United States | Equity |
| Bio-Techne Corp. | 3.430% | United States | Equity |
| Arrowhead Pharmaceuticals Inc. | 3.380% | United States | Equity |
| Biogen Inc. | 3.360% | United States | Equity |
| Exelixis Inc. | 3.300% | United States | Equity |
| Incyte Corp. | 3.180% | United States | Equity |